“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: ADAMTS13-induced destabilization of the von Willebrand factor A2 domain

€3.03

SKU: product-article-19235 Category: General

Description
Reviews (0)

Description

ADAMTS13-induced destabilization of the von Willebrand factor A2 domain

Reviews

There are no reviews yet.

Be the first to review “Article: ADAMTS13-induced destabilization of the von Willebrand factor A2 domain”

You must be logged in to post a review.

Top

Article: ADAMTS13-induced destabilization of the von Willebrand factor A2 domain

Description

Reviews

Related products

Article: Calendar of events

Article: Highlights in melanoma

Article: Highlights in respiratory oncology

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma